Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Melani Pestaña Fernández"'
Autor:
Claudia Josa-Laorden, Anxela Crestelo-Vieitez, María del Mar García Andreu, Manuel Rubio-Rivas, Marcos Sánchez, Neera Toledo Samaniego, Francisco Arnalich Fernández, Rosario Iguaran Bermudez, Eva Ma Fonseca Aizpuru, Juan Antonio Vargas Núñez, Paula Maria Pesqueira Fontan, Jorge Serrano Ballesteros, Santiago Jesús Freire Castro, Melani Pestaña Fernández, Alba Viana García, Victoria Nuñez Rodriguez, Vicente Giner-Galvañ, Francisco Javier Carrasco Sánchez, Almudena Hernández Milián, Marta Cobos-Siles, Jose Javier Napal Lecumberri, Virginia Herrero García, Maria de los Reyes Pascual Pérez, Jesús Millán Núñez-Cortés, José Manuel Casas Rojo, on behalf of the SEMI-COVID-19 Network
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5, p 899 (2021)
There is some evidence that male gender could have a negative impact on the prognosis and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of the present study was to compare the characteristics of coronavir
Externí odkaz:
https://doaj.org/article/d7b0e4ee08a44fe2a960137f6f4534f9
Autor:
Iñigo Les, Jose Loureiro-Amigo, Ferran Capdevila, Isabel Oriol, Iñaki Elejalde, Judit Aranda-Lobo, Joao Modesto, Elena Güell-Farré, Ruth García, Anna Murgadella-Sancho, Javier Anniccherico, Miguel Martín-Fernández, José Javier Lorza, Joan-Pol Monteys-Montblanch, Julián Librero, Sara Pintado-Lalueza, Marina Delgado, Berta Gracia-García, Julio Sánchez-Álvarez, Melani Pestaña-Fernández, Patricia Fanlo, Gisela Funalleras-Puig, Maite Sarobe, Eduardo Mediavilla, Carlos Ibero
Publikováno v:
Frontiers in medicine. 9
BackgroundCorticosteroids are the cornerstone of the treatment of patients with COVID-19 admitted to hospital. However, whether corticosteroids can prevent respiratory worsening in hospitalized COVID-19 patients without oxygen requirements is current
Autor:
A. Argibay, Carmen Pilar Simeón-Aznar, B. Marí-Alfonso, Luis Trapiella-Martínez, Ana Belén Madroñero-Vuelta, Dolores Colunga-Argüelles, Norberto Ortego-Centeno, Mayka Freire, Adela Marín-Ballvé, Alfredo Guillén-Del-Castillo, Manuel Rubio-Rivas, A.J. Chamorro, Cristina Gonzalez-Echavarri, Jose Antonio Todolí-Parra, Antoni Castro-Salomó, Gema María Lledó, José Antonio Vargas-Hitos, Xavier Pla-Salas, Vicent Fonollosa-Pla, Melani Pestaña-Fernández, Carles Tolosa-Vilella, María Esther Sánchez-García, Luis Sáez-Comet
Publikováno v:
Rheumatology (Oxford, England)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Introduction Endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i) are beneficial in pulmonary arterial hypertension (PAH) and digital ulcers (DU) and prevent from DU recurrences. Our study aimed to determine the differenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e388d761b4f7a7db9f19fa291f027498
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13245
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13245
Autor:
Melani, Pestaña-Fernández, Manuel, Rubio-Rivas, Carles, Tolosa-Vilella, Alfredo, Guillén-Del-Castillo, Mayka, Freire, Jose Antonio, Vargas-Hitos, Jose Antonio, Todolí-Parra, Mónica, Rodríguez-Carballeira, Adela, Marín-Ballvé, Gerard, Espinosa, Dolores, Colunga-Argüelles, Norberto, Ortego-Centeno, Luis, Trapiella-Martínez, Cristina, Carbonell-Muñoz, Xavier, Pla-Salas, Isabel, Perales-Fraile, Xavier, Corbella, Vicent, Fonollosa-Pla, Carmen Pilar, Simeón-Aznar, J A, Vargas-Hitos
Publikováno v:
The Journal of rheumatology. 47(1)
Objective.Monotherapy is an option as first-line therapy for pulmonary arterial hypertension (PAH). However, combination therapy is a beneficial alternative. Our objective was to evaluate the efficacy of monotherapy versus combination therapy in pati
Autor:
Iñigo Les, Jose Loureiro-Amigo, Ferran Capdevila, Isabel Oriol, Iñaki Elejalde, Judit Aranda-Lobo, Joao Modesto, Elena Güell-Farré, Ruth García, Anna Murgadella-Sancho, Javier Anniccherico, Miguel Martín-Fernández, José Javier Lorza, Joan-Pol Monteys-Montblanch, Julián Librero, Sara Pintado-Lalueza, Marina Delgado, Berta Gracia-García, Julio Sánchez-Álvarez, Melani Pestaña-Fernández, Patricia Fanlo, Gisela Funalleras-Puig, Maite Sarobe, Eduardo Mediavilla, Carlos Ibero
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundCorticosteroids are the cornerstone of the treatment of patients with COVID-19 admitted to hospital. However, whether corticosteroids can prevent respiratory worsening in hospitalized COVID-19 patients without oxygen requirements is current
Externí odkaz:
https://doaj.org/article/304c4229eff64016a9aed6b3a949a2e5